ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 100 | -93.8% | 0.00% | – |
| Q3 2022 | $12,000 | +50.0% | 1,622 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 1,622 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -20.0% | 1,622 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -16.7% | 1,622 | +8.3% | 0.00% | – |
| Q2 2021 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 1,498 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | – | 1,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |